AtriCure (ATRC) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $58.96 -0.27%
EPS Growth %: -300.0%
Financial Fact:
Revenue: 38.34M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -300.0%
Financial Fact:
Revenue: 38.34M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $42.2 million versus the consensus estimate of $43.44 million.
Guidance:
Sees FY 2017 revenues up 11-13%
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
- Barclays says AI trade is maturing, favors greater diversification
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
